Lilly gets FDA warning on plant that makes Humalog ingredient

02/24/2010 | Wall Street Journal, The

Eli Lilly and Co. received a warning letter from the FDA citing its lack of "sufficient corrective actions" on manufacturing violations at a Puerto Rican plant that produces the active ingredient in diabetes drug Humalog. A Lilly spokesman said the drugmaker is working to address the concern and that the matter has "no safety and efficacy implications for patients."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX